Abiopharma

🔍 Laschinger Mary A (Director)

Company: STANLEY BLACK & DECKER, INC. (SWK)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 2,603 shares of Common Stock (Direct)
  Date: 2026-05-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,603.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: 100% vested upon grant. Represents number of shares to be delivered upon settlement of restricted stock units. The reporting person has elected to defer settlement of such restricted stock units under the Stanley Black & Decker, Inc. 2020 Restricted Stock Unit Deferral Plan for Non-Employee Directors. Such restricted stock units will be settled on the 90th day following the date the director ceases to be a member of the Board, either in one lump sum or in three, five or ten annual installments.